A comprehensive review of histopathological findings of infections induced by COVID-19
Autor: | Sara Shahriyari, Sahar Mohammed Zaki Abdullah, Salah Tofik Jalal Balaky, Markov Alexander, Elham Kazemi, Ayad F. Alkaim, Fariba Tabari, Marwah Suliman Maashi |
---|---|
Rok vydání: | 2020 |
Předmět: |
Pathology
medicine.medical_specialty Lung medicine.diagnostic_test business.industry SARS-CoV-2 Biopsy COVID-19 General Medicine Disease medicine.disease Pulmonary edema Kidney Immunohistochemistry Virus Pneumonia medicine.anatomical_structure Liver medicine Middle East respiratory syndrome Humans Respiratory system business |
Zdroj: | Cellular and molecular biology (Noisy-le-Grand, France). 66(7) |
ISSN: | 1165-158X |
Popis: | The severe acute respiratory syndrome (SARS)-Coronavirus (CoV2) virus, first identified in Wuhan, China, caused the coronavirus disease 2019 (COVID-19) which soon became a global pandemic, as labelled by the World Health Organization (WHO). The transmission method of the infection is primarily through droplets of various sizes. The SARS-CoV2 virus leads to a severe respiratory illness which in the first place causes the simulation of the acute respiratory syndrome. In order to diagnose of COVID-19 efficiently, samples with infection probability need to be examined through histopathological methods. Survival chances of the infected can remarkably increase if the virus is diagnosed timely by reverse transcription-polymerase chain reaction (RT-PCR) or computed tomography (CT) scan of the chest. One of the destructive effects of COVID-19 is the formation of ground-glass opacity (GGO) in the lungs which might be regarded to be equivalent to high-altitude pulmonary edema (HAPE). COVID-19 acts very similarly to SARS and Middle East Respiratory Syndrome (MERS) which can be inactivated by the chemical compounds of ethanol and sodium hypochlorite. Epidemiologic characteristics of COVID-19 have been indicated by numerous studies; however, there is still a lack of details of pathologic changes in the lung. The present comprehensive review is an attempt to assess and cover the current state of knowledge on COVID-19 disease based on the histopathologic studies conducted before May 2020. |
Databáze: | OpenAIRE |
Externí odkaz: |